Industry leaders and innovative disruptors rely on our life sciences litigators to win their highest-stakes disputes. Our team is part of an Orrick trial platform recognized for excellence. We were the only firm named both an American Lawyer Litigation Department of the Year finalist and IP Litigation Department of the Year finalist in 2023, and we’ve landed on the National Law Journal’s Appellate Hot List 12 times.
We combine deep understanding of how life sciences companies operate, the science behind their innovations and the market to resolve complex claims involving intellectual property, product liability and mass torts, employment and white collar. We have won in appellate courts nationwide, including establishing important industry precedent, and bring deep experience in the arbitration of life sciences claims globally.
We use innovative strategies and a sophisticated data, technology and trial platform to achieve results effectively and efficiently, including:
Our IP team, with 57 lawyers holding technical degrees including 7 PhDs, understands our life sciences clients’ inventions and how to explain them to juries and judges. We have particular strength in emerging fields of innovation, including bispecific antibody, next-generation sequencing, CRISPR and CAR T disputes, as well as general biopharma and medical device litigation.
Our Chambers Band 1-ranked product liability team represents pharmaceutical and medical technology companies in high-stakes product liability and mass tort litigation. We have experience in the toughest jurisdictions – and our opponents know we are trial-ready.
Our arbitration team – recognized in the GAR 30 for seven consecutive years – knows their way around arbitral tribunals and courts around the world and has represented major pharmaceutical and biotech companies throughout the U.S., Europe and Asia.
Recognized as a five-time Law360 Employment Group of the Year, our team has secured recent wins in wage and hour, discrimination, retaliation and whistleblower litigation, and counsels life sciences companies on compliance programs to avoid enforcement and litigation risk.
We defend life sciences companies and executives in government investigations and civil litigation, including in matters under the U.S. Foreign Corrupt Practices Act, the Anti-Kickback Statute and the False Claims Act, as well as in regulatory investigations and audits. We conduct internal investigations and have particular experience in whistleblower matters.
Our nationally recognized team backs up our results on appeal and is often brought in to reverse losses in matters we did not work on. We bring a record of overturning nine-figure judgments involving novel medical technology and blockbuster drugs – including the largest patent verdict in history on behalf of Kite Pharma.